drugset / Trial / NCT04464551
The Absorption, Metabolism and Excretion of [14C]D-0316 in Human
NaSingle-groupOpen-labelOther
Summary
This is a single-center, open-label, single-dose phase I study to investigate the absorption, metabolism and excretion of \[14C\] D-0316 in healthy Chinese male subjects. The study will be conducted into two steps:Firstly, 2 subjects are enrolled in to participate in the pilot study to grope for the completion date of plasma, urine and feces sampling on the 3rd day post-dose and onwards. Then, the collection time of blood and excreta samples (urine and feces) from the subsequent 2-4 subjects will be adjusted according to the pilot study
Timeline
- Start
- 2020-12-05
- Primary completion
- 2021-08
- Completion
- 2021-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Befotertinib | Small molecule | 75 mg | Oral |